GlassScriptPhysician profile
James Joseph Glazier
NPI 1346280260
$1,274.98
in general payments reported to CMS, 2019-2025
8 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $166 · 2022: $203 · 2023: $233 · 2024: $64.53 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $553.43 | 2022-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Abbott Laboratories | $161.17 | 2019 | |
| Bard Peripheral Vascular, INC. | $149.36 | 2020 | |
| Boston Scientific Corporation | $140.36 | 2025 | Emblem Mri S-Icd |
| W. L. Gore & Associates, INC. | $132.95 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.07 | 2020-2023 | Lifevest |
| Glaxosmithkline, LLC. | $22.14 | 2025 | Arexvy, Shingrix |
| Kestra Medical Technology Services, INC. | $17.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Glazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.